Viewing Study NCT05029102


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2025-12-26 @ 3:02 AM
Study NCT ID: NCT05029102
Status: RECRUITING
Last Update Posted: 2024-02-12
First Post: 2021-08-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: TAS-102 and Anlotinib in ≥3 Lines mGC
Sponsor: Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module